Clinical Trial Update: Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation [Phase 2]

View source ↗

Summary

This clinical trial update reports that the Phase 2 study of Sotrastaurin acetate for relapsed or refractory chronic lymphocytic leukemia, small lymphocytic lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Mantle Cell Lymphoma
• Prolymphocytic Leukemia
• Richter Syndrome
• Small Lymphocytic Lymphoma

Drugs mentioned

• Sotrastaurin acetate (Sotrastaurin)

Snippet

Sponsor: James Blachly | Conditions: Prolymphocytic Leukemia, Recurrent Mantle Cell Lymphoma | Phase 2 | Status: WITHDRAWN